<DOC>
	<DOCNO>NCT00643201</DOCNO>
	<brief_summary>The purpose study evaluate effect investigational blood thinner , apixaban , prevent venous thromboembolic ( VTE ) recurrence death patient deep vein thrombosis ( DVT ) pulmonary embolism ( PE )</brief_summary>
	<brief_title>Efficacy Safety Study Apixaban Treatment Deep Vein Thrombosis Pulmonary Embolism</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Men woman â‰¥ 18 year age Clinical diagnosis DVT PE Contraindications enoxaparin warfarin Active bleeding high risk serious bleed Short life expectancy Uncontrolled high blood pressure Significantly impair kidney liver function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>